MAB as a form of inorganic growth: Clerph and Inkemia

, , ,
Integral service around a transaction
BY : Diego GutiérrezMay Thu, 2016
One of the advantages of a MAB listing is the generation of liquidity that allows the company to grow inorganically. As proof of this, in the last year we have seen several companies from very different sectors listed on the MAB that have made acquisitions, such as Clerph, Inkemia, or Bionaturis.


Clerhp buys Construcciones Guamora Paraguay

Clerhp was listed on the Mab in March this year and at the end of April, it announced the purchase of a company in Paraguay, Construcciones Guamora Paraguay.

This engineering company saw Mab as an opportunity to advance its expansion strategy, focused on countries with high growth potential, such as Latin America.

Prior to the Mab listing, the company conducted a capital increase 1.05m, which will allow it to address its expansion plan "organically", through the opening of new subsidiaries. It is currently present in Spain, Bolivia and Brazil.

Now, with the Mab listing, the company is looking to grow inorganically, through the purchase of small companies, as well as through alliances with local engineering firms that are well positioned in their home markets.

The first purchase it has made is an engineering company in Paraguay, which allows it to enter this country, one of the strategic markets in its expansion policy. The other countries Clerhp has its eye on are Bolivia and Brazil.

Inkemia : enters Pharmamel, participates in the capital increase of Mind the Byte and acquires a stake of €145,000 in CIMER S.A.

Inkemia was floated on Mab in 2012 and has been very active ever since. In addition to creating several startups, through its subsidiary IUCT Emprén, it has participated in several startups.

Last year Inkemia entered into Pharmamela spin-off of the University of Granada founded in 2014 and focused on the development of cosmetic and health products in the field of cellular ageing and their application to the skin.

The entry was made by leading the company's capital increase.

Inkemia also participated in the capital increase made by MindTheByte, a company specialising in the development and provision of services through scientific cloud solutions and data analysis.

Inkemia covered 10% of the planned €100,000 increase.

This year 2016, Inkemia has acquired a stake of €145,000 in CIMER S.A. This stake has been made through a loan of €145,000 that can be converted into shares in the company Centro Internacional de Medicina Regenerativa Biomed (CIMER).

In addition to Inkemia, as we mentioned in a post a few weeks ago, another biotech company on the Mab, Bionaturis, has also recently bought a company, BBD BIOPHENIX S. L.

Other posts that may interest you

Clerhp structures exits the mab up 10.24%

TECNOQUARK goes public on the MAB to finance growth

Oryzon genomics floats on the MAB

If you are thinking of going public on Mab, contact us. Abra.Invest has an expert team that can help you to make your Mab listing a success. Call us on + 34 946424142 or fill in the contact form.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?